Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies-Reference-Cited by-同舟云学术

Utrophin modulator drugs as potential therapies for Duchenne and Becker muscular dystrophies

Published:2021-06-04 Issue:6 Volume:47 Page:711-723
ISSN:0305-1846
Container-title:Neuropathology and Applied Neurobiology
language:en
Short-container-title:Neuropathol Appl Neurobiol

Author:

Soblechero‐Martín Patricia¹²^ORCID,López‐Martínez Andrea¹^ORCID,Puente‐Ovejero Laura¹^ORCID,Vallejo‐Illarramendi Ainara³^ORCID,Arechavala‐Gomeza Virginia¹⁴^ORCID

Affiliation:

1. Neuromuscular Disorders Biocruces Bizkaia Health Research Institute Barakaldo Spain

2. Clinical Laboratory Service Osakidetza Basque Health Service Bilbao‐Basurto Integrated Health Organisation Basurto University Hospital Bilbao Spain

3. Departamento Pediatría Hospital Donostia ‐ IIS Biodonostia UPV/EHU Donostia‐San Sebastián Spain

4. Ikerbasque Basque Foundation for Science Bilbao Spain

Funder

Ikerbasque, Basque Foundation for Science

Instituto de Salud Carlos III

European Regional Development Fund

Osasun Saila, Eusko Jaurlaritzako

Publisher

Wiley

Subject

Physiology (medical),Clinical Neurology,Neurology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nan.12735

Reference122 articles.

1. Dystrophin: The protein product of the duchenne muscular dystrophy locus

2. The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review

3. Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis

4. The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion;Koenig M;Am J Hum Genet,1989

5. Real-world outcomes of long-term prednisone and deflazacort use in patients with Duchenne muscular dystrophy: experience at a single, large care center

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular and Biochemical Therapeutic Strategies for Duchenne Muscular Dystrophy;Neurology International;2024-07-05

2. The Role of MicroRNA in the Pathogenesis of Duchenne Muscular Dystrophy;International Journal of Molecular Sciences;2024-06-01

3. 3D-QSAR Modeling on 2-Pyrimidine Carbohydrazides as Utrophin Modulators for the Treatment of Duchenne Muscular Dystrophy by Combining CoMFA, CoMSIA, and Molecular Docking Studies;ACS Omega;2024-05-31

4. Rare genetic disorders in India: Current status, challenges, and CRISPR-based therapy;Journal of Biosciences;2024-02-19

5. How Can Proteomics Help to Elucidate the Pathophysiological Crosstalk in Muscular Dystrophy and Associated Multi-System Dysfunction?;Proteomes;2024-01-16